Richard Schilsky to Receptor, Fibroblast Growth Factor, Type 2
This is a "connection" page, showing publications Richard Schilsky has written about Receptor, Fibroblast Growth Factor, Type 2.
Connection Strength
0.243
-
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Feb; 8:e2300513.
Score: 0.243